✨ Your Portfolio is fetched and updated from zerodha.

Emcure Pharmaceuticals Ltd.

EMCURE

Market Cap
₹22,211 Cr.
P/E
44.58

Emcure Pharmaceuticals Ltd.

  • Emcure Pharma
  • Natco Pharma
  • Concord Biotech
FAQs on Emcure Pharmaceuticals Ltd. Shareprice

There is not enough historical data for the companies share price.

Emcure Pharma is not expensive.
Latest PE of Emcure Pharma is 44.58, while 3 year average PE is 52.26.
Also latest EV/EBITDA of Emcure Pharma is 16.66 while 3yr average is 19.64.

View FAQ's On Business
Growth Table
  • Emcure Pharmaceuticals Ltd.
  • Natco Pharma
  • Concord Biotech
Balance Sheet
  • Emcure Pharmaceuticals Ltd.
  • Natco Pharma
  • Concord Biotech
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Emcure Pharmaceuticals Ltd.
  • Natco Pharma
  • Concord Biotech
Cash Flow
  • Emcure Pharmaceuticals Ltd.
  • Natco Pharma
  • Concord Biotech
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Emcure Pharmaceuticals Ltd.
  • Natco Pharma
  • Concord Biotech
Quarterly Results
  • Emcure Pharmaceuticals Ltd.
  • Natco Pharma
  • Concord Biotech
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Emcure Pharmaceuticals Ltd. Financials

Balance sheet of Emcure Pharma is strong.
But short term working capital might become an issue for this company.

The debt of Emcure Pharma is decreasing.
Latest debt of Emcure Pharma is ₹755 Crs as of Sep-24.
This is less than Mar-24 when it was ₹1,608 Crs.

The profit is oscillating.
The profit of Emcure Pharma is ₹630 Crs for TTM, ₹498 Crs for Mar 2024 and ₹532 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Emcure Pharma latest dividend payout ratio is 10.91% and 3yr average dividend payout ratio is 8.63%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech